TAZORAC Side Effects

6740457-4 | Burning Sensation, Erythema, Feeling Hot, Skin Irritation
on Apr 13, 2010 Female patient from UNITED STATES , 28 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, erythema, feeling hot, skin irritation. Tazorac dosage: Unk. During the same period patient was treated with ACZONE (Unk) (View Aczone Review and Aczone Label ), TRIAZ (Unk) (View Triaz Review and Triaz Label ).

6554076-6 | Rash
Patient was taking Tazorac (View Usage). Patient had the following side effects: rash (What is rash?) on Jan 25, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 130.3 lb, was diagnosed with arthritis (What is arthritis?) and. Tazorac dosage: Small Amount Prn 060.

6545877-9 | Acne, Rash
Adverse event was reported on Aug 04, 2009 by a Female patient taking Tazorac (View Usage) (Dosage: Unk) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , 27 years of age, After Tazorac was administered, patient had the following side effects: acne (What is acne?), rash (What is rash?). During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ).

6545876-7 | Erythema, Swelling Face
on Oct 01, 2009 Female patient from UNITED STATES , 15 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, swelling face. Tazorac dosage: Unk.


6545873-1 | Chapped Lips, Lip Haemorrhage, Lip Pain
on Apr 27, 2009 Female patient from UNITED STATES , 69 years of age, was diagnosed with photodermatosis and was treated with Tazorac (View Usage). Patient had the following side effects: chapped lips, lip haemorrhage, lip pain. Tazorac dosage: .

6545871-8 | Aphonia
Patient was taking Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: aphonia on Jun 17, 2009 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with tongue discolouration and. Tazorac dosage: . During the same period patient was treated with POTASSIUM (10 Meq, Unk) (View Potassium Review and Potassium Label ), NEXIUM (40 Mg, Unk) (View Nexium Review and Nexium Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ), CARDIZEM LA (240) (View Cardizem La Review and Cardizem La Label ), HYDROCHLOROTHIAZIDE (25 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LIPITOR (40 Mg, Unk) (View Lipitor Review and Lipitor Label ).

6545869-X | Dry Skin, Paraesthesia, Skin Exfoliation
Adverse event was reported on Apr 23, 2009 by a Male patient taking Tazorac (View Usage) (Dosage: Unk, Single) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , 59 years of age, Patient experienced the following unwanted or unexpected effects: dry skin, paraesthesia, skin exfoliation.

6545867-6 | Hormone Level Abnormal
on Jan 15, 2009 Female patient from UNITED STATES , 41 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient had the following side effects: hormone level abnormal. Tazorac dosage: Unk, Bid. During the same period patient was treated with SYNTHROID (0.25 Mg, Qd) (View Synthroid Review and Synthroid Label ), CYMBALTA (60 Mg, Qd) (View Cymbalta Review and Cymbalta Label ).

6545864-0 | Skin Hyperpigmentation
on Mar 20, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with rash (What is rash?) and was treated with Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: skin hyperpigmentation. Tazorac dosage: Unk, Qhs.

6545859-7 | Discomfort, Dry Skin, Erythema, Hyperaesthesia, Pain, Scab, Skin Burning Sensation, Skin Exfoliation, Skin Irritation
Patient was taking Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: discomfort, dry skin, erythema, hyperaesthesia, pain (What is pain?), scab (What is scab?), skin burning sensation, skin exfoliation, skin irritation on Aug 20, 2009 from UNITED STATES Additional patient health information: Female patient , 15 years of age, weighting 115.0 lb, was diagnosed with acne (What is acne?) and. Tazorac dosage: . During the same period patient was treated with BENZOYL PEROXIDE (Unk) (View Benzoyl Peroxide Review and Benzoyl Peroxide Label ), KLARON (Unk) (View Klaron Review and Klaron Label ), MOISTURIZER (View Moisturizer Review and Moisturizer Label ).

6369133-7 | Rash, Urticaria
Adverse event was reported on Dec 03, 2008 by a Female patient taking Tazorac (View Usage) (Dosage: ) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , 18 years of age, Patient had the following side effects: rash (What is rash?), urticaria. During the same period patient was treated with AZELEX (Unk, Qam) (View Azelex Review and Azelex Label ), RETIN A (Unk, Qpm) (View Retin-a Review and Retin-a Label ), BENZACLIN (View Benzaclin Review and Benzaclin Label ).

5964880-0 | Caesarean Section, Complication Of Delivery
on Nov 24, 2008 Female patient from UNITED STATES , 40 years of age, weighting 160.0 lb, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: caesarean section, complication of delivery. Tazorac dosage: .

5942427-2 | Atrial Septal Defect, Patent Ductus Arteriosus, Supraventricular Extrasystoles, Ventricular Septal Defect
on Oct 29, 2008 Female patient from UNITED STATES , weighting 7.00 lb, was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: atrial septal defect, patent ductus arteriosus, supraventricular extrasystoles, ventricular septal defect. Tazorac dosage: Unk, Qhs.

5055763-1 | Abortion Spontaneous, Blood Human Chorionic Gonadotropin Increased, Complication Of Pregnancy, Ultrasound Scan Abnormal
Patient was taking Tazorac (View Usage). Patient had the following side effects: abortion spontaneous, blood human chorionic gonadotropin increased, complication of pregnancy, ultrasound scan abnormal on Jun 30, 2006 from UNITED STATES Additional patient health information: Female patient , 24 years of age, . Tazorac dosage: Unk, Qd, Topical.

5045022-5 | Abortion Spontaneous, Blood Human Chorionic Gonadotropin Increased, Pregnancy, Ultrasound Scan Abnormal, Vaginal Haemorrhage
Adverse event was reported on Jun 21, 2006 by a Female patient taking Tazorac (View Usage) (Dosage: Qd, Topical) . Location: UNITED STATES , 24 years of age, After Tazorac was administered, patient had the following side effects: abortion spontaneous, blood human chorionic gonadotropin increased, pregnancy (What is pregnancy?), ultrasound scan abnormal, vaginal haemorrhage.

4969410-8 | Aortic Aneurysm, Blister, Cholecystitis Acute, Cholecystitis Chronic, Condition Aggravated, Contusion, Dermatitis, Erythema, Hypersensitivity
on Mar 29, 2006 Female patient from UNITED STATES , 62 years of age, weighting 174.0 lb, was diagnosed with psoriasis and was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: aortic aneurysm (What is aortic aneurysm?), blister, cholecystitis acute, cholecystitis chronic, condition aggravated, contusion, dermatitis, erythema, hypersensitivity. Tazorac dosage: . During the same period patient was treated with PROTOPIC (View Protopic Review and Protopic Label ), OLUX FOAM (View Olux Foam Review and Olux Foam Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ESTROPIPATE (View Estropipate Review and Estropipate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROZAC (View Prozac Review and Prozac Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

4938803-7 | Blister, Burning Sensation, Cholecystectomy, Contusion, Dermatitis, Hypersensitivity, Pain Of Skin, Platelet Count Increased, Skin Discolouration
on Jan 05, 2006 Female patient from UNITED STATES , 62 years of age, weighting 174.0 lb, was diagnosed with psoriasis and was treated with Tazorac (View Usage). Patient had the following side effects: blister, burning sensation, cholecystectomy, contusion, dermatitis, hypersensitivity, pain of skin, platelet count increased, skin discolouration. Tazorac dosage: . During the same period patient was treated with PROTOPIC (View Protopic Review and Protopic Label ), OLUX FOAM (View Olux Foam Review and Olux Foam Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ESTROPIPATE (View Estropipate Review and Estropipate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROZAC (View Prozac Review and Prozac Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

4869828-8 | Feeding Disorder Neonatal, Laryngomalacia, Neonatal Disorder, Oesophageal Atresia, Single Umbilical Artery, Tracheo-oesophageal Fistula, Tracheomalacia
Patient was taking Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: feeding disorder neonatal, laryngomalacia, neonatal disorder, oesophageal atresia, single umbilical artery, tracheo-oesophageal fistula, tracheomalacia on Dec 12, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 6.54 lb, . Tazorac dosage: . Patient was hospitalized.

4846251-3 | Congenital Anomaly, Congenital Oesophageal Anomaly, Crying, Feeding Disorder Neonatal, Gastrooesophageal Reflux Disease, Laryngomalacia, Neonatal Disorder, Oesophageal Atresia
Adverse event was reported on Nov 16, 2005 by a Male patient taking Tazorac (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 6.54 lb, Patient experienced the following unwanted or unexpected effects: congenital anomaly, congenital oesophageal anomaly, crying, feeding disorder neonatal, gastrooesophageal reflux disease, laryngomalacia, neonatal disorder, oesophageal atresia. Patient was hospitalized.

4846151-9 | Bed Rest, Pre-eclampsia, Pregnancy, Single Umbilical Artery
on Nov 16, 2005 Female patient from UNITED STATES , 33 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient had the following side effects: bed rest, pre-eclampsia, pregnancy (What is pregnancy?), single umbilical artery. Tazorac dosage: . During the same period patient was treated with PRENATAL VITAMINS (View Prenatal Vitamins Review and Prenatal Vitamins Label ).

4835353-3 | Abortion Spontaneous
on Sep 29, 2005 Female patient from UNITED STATES , weighting 143.0 lb, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: abortion spontaneous. Tazorac dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

4753225-X | Fatigue, Hodgkin's Disease, Hypoglycaemia, Pregnancy
Patient was taking Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, hodgkin's disease (What is hodgkin's disease?), hypoglycaemia, pregnancy (What is pregnancy?) on Aug 09, 2005 from UNITED STATES Additional patient health information: Female patient , 32 years of age, weighting 147.7 lb, was diagnosed with acne (What is acne?), psoriasis and. Tazorac dosage: 3% Qod Tp. During the same period patient was treated with DOVONEX (View Dovonex Review and Dovonex Label ), DIPROLENE (View Diprolene Review and Diprolene Label ).

4751068-4 | Benign Intracranial Hypertension, Brain Oedema, Mydriasis, Post Procedural Complication
Adverse event was reported on Aug 08, 2005 by a Female patient taking Tazorac (View Usage) (Dosage: ) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , 14 years of age, weighting 111.0 lb, Patient had the following side effects: benign intracranial hypertension, brain oedema, mydriasis, post procedural complication. During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ).

4736355-8 | Pre-eclampsia, Pregnancy, Single Umbilical Artery
on Jul 20, 2005 Female patient from UNITED STATES , 33 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: pre-eclampsia, pregnancy (What is pregnancy?), single umbilical artery. Tazorac dosage: .

4723917-7 | Benign Intracranial Hypertension, Brain Oedema, Headache, Nausea, Post Procedural Complication
on Jul 11, 2005 Female patient from UNITED STATES , 14 years of age, weighting 11.00 lb, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: benign intracranial hypertension, brain oedema, headache (What is headache?), nausea (What is nausea?), post procedural complication. Tazorac dosage: . During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ).

4707058-0 | Anencephaly, Premature Baby, Twin Pregnancy
Patient was taking Tazorac (View Usage). Patient had the following side effects: anencephaly, premature baby, twin pregnancy on Jun 20, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 2.45 lb, was diagnosed with acne (What is acne?) and. Tazorac dosage: .

4707042-7 | Caesarean Section, Pregnancy, Premature Labour
Adverse event was reported on Jun 20, 2005 by a Female patient taking Tazorac (View Usage) (Dosage: ) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , 32 years of age, After Tazorac was administered, patient had the following side effects: caesarean section, pregnancy (What is pregnancy?), premature labour. Patient was hospitalized.

4707009-9 | Anencephaly, Patent Ductus Arteriosus, Premature Baby, Twin Pregnancy, Ventricular Septal Defect
on Jun 20, 2005 Female patient from UNITED STATES , weighting 2.45 lb, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: anencephaly, patent ductus arteriosus, premature baby, twin pregnancy, ventricular septal defect. Tazorac dosage: . Patient was hospitalized.

4674379-X | Benign Intracranial Hypertension, Brain Oedema, Lumbar Puncture Headache
on May 12, 2005 Female patient from , 14 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient had the following side effects: benign intracranial hypertension, brain oedema, lumbar puncture headache. Tazorac dosage: . During the same period patient was treated with DOXYCYCLINE (Acne) (View Doxycycline Review and Doxycycline Label ).

4657475-2 | Abortion Spontaneous
Patient was taking Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: abortion spontaneous on Apr 26, 2005 from Additional patient health information: Female patient , 39 years of age, was diagnosed with acne (What is acne?) and. Tazorac dosage: .

4652980-7 | Anencephaly, Pregnancy, Premature Baby
Adverse event was reported on Apr 18, 2005 by a Female patient taking Tazorac (View Usage) (Dosage: ) was diagnosed with acne (What is acne?) and. Location: , weighting 2.45 lb, Patient experienced the following unwanted or unexpected effects: anencephaly, pregnancy (What is pregnancy?), premature baby.

4652977-7 | Anencephaly, Caesarean Section, Premature Labour, Twin Pregnancy
on Apr 18, 2005 Female patient from , 32 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient had the following side effects: anencephaly, caesarean section, premature labour, twin pregnancy. Tazorac dosage: . Patient was hospitalized.

4652976-5 | Anencephaly, Patent Ductus Arteriosus, Premature Labour, Twin Pregnancy
on Apr 18, 2005 Female patient from , weighting 2.45 lb, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: anencephaly, patent ductus arteriosus, premature labour, twin pregnancy. Tazorac dosage: . Patient was hospitalized.

4634726-1 | Aplasia Cutis Congenita, Double Ureter, Kidney Infection, Urinary Tract Infection
Patient was taking Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia cutis congenita, double ureter, kidney infection, urinary tract infection (What is urinary tract infection?) on Mar 30, 2005 from Additional patient health information: Female patient , weighting 6.88 lb, . Tazorac dosage: . During the same period patient was treated with TRIAZ (View Triaz Review and Triaz Label ).

4565644-5 | Anencephaly, Premature Baby
Adverse event was reported on Jan 11, 2005 by a Female patient taking Tazorac (View Usage) (Dosage: ) was diagnosed with acne (What is acne?) and. Location: , weighting 2.45 lb, Patient had the following side effects: anencephaly, premature baby.

4562701-4 | Caesarean Section, Pregnancy
on Sep 24, 2001 Female patient from , 33 years of age, was diagnosed with psoriasis and was treated with Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: caesarean section, pregnancy (What is pregnancy?). Tazorac dosage: .

4562195-9 | Pilonidal Cyst Congenital
on Jan 06, 2005 Male patient from , weighting 6.81 lb, was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: pilonidal cyst congenital. Tazorac dosage: .

4561862-0 | Breech Presentation, Caesarean Section, Nail Discolouration, Nail Disorder, Neonatal Disorder, Onychomadesis, Pregnancy
Patient was taking Tazorac (View Usage). Patient had the following side effects: breech presentation, caesarean section, nail discolouration, nail disorder, neonatal disorder, onychomadesis, pregnancy (What is pregnancy?) on Jan 12, 2005 from Additional patient health information: Male patient , weighting 8.55 lb, . Tazorac dosage: . During the same period patient was treated with CITRACAL (View Citracal Review and Citracal Label ).

4561510-X | Abortion Induced
Adverse event was reported on Aug 15, 2001 by a Female patient taking Tazorac (View Usage) (Dosage: ) was diagnosed with acne (What is acne?) and. Location: , 30 years of age, After Tazorac was administered, patient had the following side effects: abortion induced. During the same period patient was treated with TETRACYCLINE (View Tetracycline Review and Tetracycline Label ).

4561509-3 | Abortion Spontaneous
on Feb 19, 2004 Female patient from , 39 years of age, was diagnosed with acne (What is acne?) and was treated with Tazorac (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Tazorac dosage: .

4561500-7 | Premature Labour
on May 20, 2003 Female patient from , 42 years of age, was diagnosed with skin wrinkling and was treated with Tazorac (View Usage). Patient had the following side effects: premature labour. Tazorac dosage: . Patient was hospitalized.

4561499-3 | Blood Bilirubin Increased, Poor Sucking Reflex, Premature Baby, Premature Separation Of Placenta
Patient was taking Tazorac (View Usage). After Tazorac was administered, patient had the following side effects: blood bilirubin increased, poor sucking reflex, premature baby, premature separation of placenta on Jan 05, 2005 from Additional patient health information: Male patient , weighting 4.94 lb, . Tazorac dosage: . Patient was hospitalized.

4561498-1 | Aplasia Cutis Congenita, Double Ureter, Fever Neonatal, Kidney Infection, Large For Dates Baby, Neonatal Infection, Urinary Tract Infection Neonatal
Adverse event was reported on Jan 06, 2005 by a Female patient taking Tazorac (View Usage) (Dosage: ) . Location: , weighting 6.88 lb, Patient experienced the following unwanted or unexpected effects: aplasia cutis congenita, double ureter, fever neonatal, kidney infection, large for dates baby, neonatal infection, urinary tract infection neonatal. During the same period patient was treated with TRIAZ (View Triaz Review and Triaz Label ).

4561496-8 | Dyspnoea, Neonatal Disorder, Pregnancy
on Jan 06, 2005 Female patient from , weighting 8.14 lb, was treated with Tazorac (View Usage). Patient had the following side effects: dyspnoea, neonatal disorder, pregnancy (What is pregnancy?). Tazorac dosage: . Patient was hospitalized.